InsidersTradesSigma
Follow the OTOFARMA OTOFARMA: THE BOARD OF DIRECTORS APPROVES THE DRAFT FINANCIAL STATEMENTS AND CONSOLIDATED FINANCIAL STATEMENTS AS OF DECEMBER 31, 2025, REVISED THE FINANCIAL CALENDAR AND CALLS THE SHAREHOLDERS' MEETING FOR JUNE 29, 2026 (FIRST CALL) share price and the full management transaction log of the company, a publicly traded company based in Italy. Shares trade on the IT market, under the supervision of Consob. Market capitalisation: €15.5m. All data is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
No declarations found
0 of 0 declarations
OTOFARMA announced that the board of directors approved the financial statements and consolidated financial statements as of December 31, 2025. The company also revised its financial calendar and called the shareholders' meeting for June 29, 2026 (first call).